Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

A Multicenter, Prospective, Observational Study of Pola-R-CHP in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma (POLASTAR): A Preliminary Analysis

Blood (2024) 144 (Supplement 1): 4475.

https://doi.org/10.1182/blood-2024-192949

Published: 2024

Journal Articles

Efficacy and Safety of Polatuzumab-Vedotin Plus Rituximab, Cyclophosphamide, Doxorubicin and Prednisone (Pola-R-CHP) for Diffuse Large B-Cell Lymphoma in the Real-World Setting: A Single Institute Retrospective Study

Masaaki Hotta, Ayako Iwama, Tokiko Hoshiyama, Yukie Tsubokura, Hideaki Yoshimura, Yumiko Kono, Shinya Fujita, Atsushi Satake, Tomoki Ito

Blood (2023) 142 (Supplement 1): 3107.

https://doi.org/10.1182/blood-2023-173434

Published: 2023

Journal Articles

Mutational Analysis of DNMT3A Improves the Prognostic Stratification Using NPM1 / FLT3 -ITD Genotypes in Patients with Acute Myeloid Leukemia

Blood (2022) 140 (Supplement 1): 8914–8916.

https://doi.org/10.1182/blood-2022-158686

Published: 2022

Journal Articles

Elotuzumab Enhances the Th2-Mediated Immune Response of Dendritic Cell Induced By Immunomodulatory Drugs (IMiDs)

Yoshiko Azuma, MD, Tomoki Ito, MD PhD, Muneo Inaba, PhD, Kai Imai, MD, Masaaki Hotta, MD, Atsushi Satake, MD PhD, Shosaku Nomura, MD PhD

Blood (2019) 134 (Supplement_1): 4342.

https://doi.org/10.1182/blood-2019-129680

Published: 2019

Journal Articles

Does Neutrophil to Lymphocyte Ratio (NLR) Predict the Prognosis of Diffuse Large B-Cell Lymphoma?

Aya Nakaya, MD PhD, Shinya Fujita, MD PhD, Atsushi Satake, MD PhD, Takahisa Nakanishi, MD PhD, Yoshiko Azuma, MD, Yukie Tsubokura, MD, Ryo Saito, MD, Akiko Konishi, MD, Masaaki Hotta, MD, Hideaki Yoshimura, MD, Kazuyoshi Ishii, MD MPH, PhD, Tomoki Ito, MD PhD, Shosaku Nomura, MD PhD

Blood (2018) 132 (Supplement 1): 5402.

https://doi.org/10.1182/blood-2018-99-117823

Published: 2018

Journal Articles

Myeloma Cells Have the Ability to Suppress Th1-Inducing Capacity but Enhance Th2-Mediated Response of Dendritic Cells By Producing Factors Other Than Soluble SLAMF7

Yoshiko Azuma, MD, Tomoki Ito, MD PhD, Muneo Inaba, PhD, Kai Imai, MD, Hideaki Yoshimura, MD, Masaaki Hotta, MD, Takahisa Nakanishi, MD PhD, Shinya Fujita, MD PhD, Aya Nakaya, MD PhD, Atsushi Satake, MD PhD, Kazuyoshi Ishii, MDMPH,PhD, Shosaku Nomura, MD PhD

Blood (2018) 132 (Supplement 1): 1938.

https://doi.org/10.1182/blood-2018-99-113282

Published: 2018

Journal Articles

A Critical Role of Host-Derived Semaphorin-4A for Regulating T Cell Immune Responses in Acute Graft Versus Host Disease

Hideaki Yoshimura, MD, Yukie Tsubokura, MD, Masaaki Hotta, MD, Atsushi Satake, MD PhD, Tomoki Ito, MD PhD, Atsushi Kumanogoh, MD PhD, Shosaku Nomura, MD PhD

Blood (2018) 132 (Supplement 1): 3322.

https://doi.org/10.1182/blood-2018-99-113853

Published: 2018

Journal Articles

Clinical Impact of Mogamulizumab Against Aggressive ATL: A Single-Center Retrospective Analysis

Atsushi Satake, MD PhD, Yoshiko Azuma, MD, Yukie Tsubokura, MD, Hideaki Yoshimura, MD, Masaaki Hotta, MD, Takahisa Nakanishi, MD PhD, Shinya Fujita, MD PhD, Aya Nakaya, MD PhD, Tomoki Ito, MD PhD, Kazuyoshi Ishii, Shosaku Nomura, MD PhD

Blood (2017) 130 (Supplement 1): 4092.

https://doi.org/10.1182/blood.V130.Suppl_1.4092.4092

Published: 2017

Journal Articles

Lenalidomide Acts As a Positive Immunomodulator through Modulating the Functions of Human Plasmacytoid Dendritic Cells

Tomoki Ito, MD PhD, Kayoko Kibata, MD, Muneo Inaba, PhD, Yoshiko Azuma, MD, Yukie Tsubokura, MD, Hideaki Yoshimura, MD, Masaaki Hotta, MD, Takahisa Nakanishi, MD PhD, Shinya Fujita, MD PhD, Aya Nakaya, MD PhD, Atsushi Satake, MD PhD, Kazuyoshi Ishii, MDMPH,PhD, Shosaku Nomura, MD PhD

Blood (2017) 130 (Supplement 1): 1007.

https://doi.org/10.1182/blood.V130.Suppl_1.1007.1007

Published: 2017

Journal Articles

Immunomodulatory Drugs (IMiDs), Lenalidomide and Pomalidomide, Suppress Th1-Inducing Capacity of Dendritic Cells but Enhance Th2-Mediated Allergic Response

Tomoki Ito, M. D. and Ph. D., Phan Thi Xuan Vien, Muneo Inaba, Ph. D, Hideaki Yoshimura, MD, Masaaki Hotta, MD, Takahisa Nakanishi, MD PhD, Shinya Fujita, MD PhD, Aya Nakaya, MD PhD, Atsushi Satake, MD PhD, Kazuyoshi Ishii, MD MPH, PhD, Shosaku Nomura, MD PhD

Blood (2016) 128 (22): 2520.

https://doi.org/10.1182/blood.V128.22.2520.2520

Published: 2016

Journal Articles

GM-CSF Therapy Expands Regulatory T Cells and Protects Against Chronic Graft Versus Host Disease

Hideaki Yoshimura, MD, Masaaki Hotta, MD, Atsushi Satake, MD PhD, Shosaku Nomura, MD PhD

Blood (2016) 128 (22): 2151.

https://doi.org/10.1182/blood.V128.22.2151.2151

Published: 2016

Journal Articles

NKG2D expression by CD8 + T cells contributes to GVHD and GVT effects in a murine model of allogeneic HSCT

Mobin A. Karimi, Jerrod L. Bryson, Lee P. Richman, Andrew D. Fesnak, Theresa M. Leichner, Atsushi Satake, Robert H. Vonderheide, David H. Raulet, Ran Reshef, Taku Kambayashi

Blood (2015) 125 (23): 3655–3663.

https://doi.org/10.1182/blood-2015-02-629006

Published: 2015

Includes: Supplemental data

Journal Articles

Transient NKG2D Blockade Attenuates Graft-Versus-Host Disease While Preserving Graft-Versus-Leukemia Effects

Mobin Karimi, PhD, Theresa M Leichner, BS, Atsushi Satake, MD, PhD, David Raulet, Ph.D., Taku Kambayashi, MD, PhD

Blood (2013) 122 (21): 3242.

https://doi.org/10.1182/blood.V122.21.3242.3242

Published: 2013

Journal Articles

Evaluation Of Large Granular Lymphocytes and Endothelial-Cell-Related Biomarkers In Patients With Chronic Myeloblastic Leukemia: Comparison Among 3 TKIs

Tomoki Ito, MD, PhD, Nobuhiko Uoshima, MD, PhD, Yasuhiro Maeda, Masaaki Hotta, Hideaki Yoshomura, Shinya Fujita, Atsushi Satake, MD, PhD, Kazuyoshi Ishii, MD, MPH, PhD, Fumiaki Urase, Kunio Hayashi, PhD/MD, Shosaku Nomura, MD, PhD

Blood (2013) 122 (21): 5167.

https://doi.org/10.1182/blood.V122.21.5167.5167

Published: 2013

Journal Articles

Differential Targeting of Signaling Pathways to Selectively Expand Mouse Regulatory T Cells While Inhibiting Conventional T Cells.

Atsushi Satake, MD, PhD, Amanda M Schmidt, Angela Archambault, Gregory F Wu, MD, PhD, Taku Kambayashi, MD, PhD

Blood (2012) 120 (21): 2158.

https://doi.org/10.1182/blood.V120.21.2158.2158

Published: 2012

Journal Articles

Cell-autonomous role of TGFβ and IL-2 receptors in CD4 + and CD8 + inducible regulatory T-cell generation during GVHD

Norifumi Sawamukai, Atsushi Satake, Amanda M. Schmidt, Ian T. Lamborn, Priti Ojha, Yoshiya Tanaka, Taku Kambayashi

Blood (2012) 119 (23): 5575–5583.

https://doi.org/10.1182/blood-2011-07-367987

Published: 2012

Includes: Supplemental data

Journal Articles

Cell Autonomous Role of TGFβ and IL-2 Receptor in the In Vivo Generation of CD4 and CD8 Inducible Regulatory T Cells During Graft-Versus-Host Disease,

Atsushi Satake, M.D., Ph.D., Norifumi Sawamukai, M.D., Ph.D., Taku Kambayashi, MD, PhD

Blood (2011) 118 (21): 4015.

https://doi.org/10.1182/blood.V118.21.4015.4015

Published: 2011

Journal Articles

MHC Class II and T Cell Receptor Signals Are Dispensable for IL-2-Induced Regulatory T Cell Proliferation In Vivo

Tao Zou, B.S., Atsushi Satake, M.D., Jonathan Maltzman, MD, PhD, Taku Kambayashi, MD, PhD

Blood (2011) 118 (21): 2181.

https://doi.org/10.1182/blood.V118.21.2181.2181

Published: 2011

NARROW

A Multicenter, Prospective, Observational Study of Pola-R-CHP in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma (POLASTAR): A Preliminary Analysis

Efficacy and Safety of Polatuzumab-Vedotin Plus Rituximab, Cyclophosphamide, Doxorubicin and Prednisone (Pola-R-CHP) for Diffuse Large B-Cell Lymphoma in the Real-World Setting: A Single Institute Retrospective Study

Mutational Analysis of DNMT3A Improves the Prognostic Stratification Using NPM1 / FLT3 -ITD Genotypes in Patients with Acute Myeloid Leukemia

Elotuzumab Enhances the Th2-Mediated Immune Response of Dendritic Cell Induced By Immunomodulatory Drugs (IMiDs)

Does Neutrophil to Lymphocyte Ratio (NLR) Predict the Prognosis of Diffuse Large B-Cell Lymphoma?

Myeloma Cells Have the Ability to Suppress Th1-Inducing Capacity but Enhance Th2-Mediated Response of Dendritic Cells By Producing Factors Other Than Soluble SLAMF7

A Critical Role of Host-Derived Semaphorin-4A for Regulating T Cell Immune Responses in Acute Graft Versus Host Disease

Clinical Impact of Mogamulizumab Against Aggressive ATL: A Single-Center Retrospective Analysis

Lenalidomide Acts As a Positive Immunomodulator through Modulating the Functions of Human Plasmacytoid Dendritic Cells

Immunomodulatory Drugs (IMiDs), Lenalidomide and Pomalidomide, Suppress Th1-Inducing Capacity of Dendritic Cells but Enhance Th2-Mediated Allergic Response

GM-CSF Therapy Expands Regulatory T Cells and Protects Against Chronic Graft Versus Host Disease

NKG2D expression by CD8 + T cells contributes to GVHD and GVT effects in a murine model of allogeneic HSCT

Transient NKG2D Blockade Attenuates Graft-Versus-Host Disease While Preserving Graft-Versus-Leukemia Effects

Evaluation Of Large Granular Lymphocytes and Endothelial-Cell-Related Biomarkers In Patients With Chronic Myeloblastic Leukemia: Comparison Among 3 TKIs

Differential Targeting of Signaling Pathways to Selectively Expand Mouse Regulatory T Cells While Inhibiting Conventional T Cells.

Cell-autonomous role of TGFβ and IL-2 receptors in CD4 + and CD8 + inducible regulatory T-cell generation during GVHD

Cell Autonomous Role of TGFβ and IL-2 Receptor in the In Vivo Generation of CD4 and CD8 Inducible Regulatory T Cells During Graft-Versus-Host Disease,

MHC Class II and T Cell Receptor Signals Are Dispensable for IL-2-Induced Regulatory T Cell Proliferation In Vivo

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only